Skip to content

Exploration of Blood Biomarkers, Including Whole Blood Viscosity as a Prognostic Factor for Acute Pancreatitis

Exploration of Blood Biomarkers, Including Whole Blood Viscosity as a Prognostic Factor for Acute Pancreatitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04553783
Enrollment
137
Registered
2020-09-17
Start date
2020-03-10
Completion date
2023-05-31
Last updated
2020-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Brief summary

This study aims to evaluate the usefulness of blood viscosity as a prognostic factor in patients with acute pancreatitis. The study design is a single-arm prospective cohort observational study. Blood biomarkers including blood viscosity, C-reactive protein, hematocrit, and phosphate are measured and the correlation with the severity of acute pancreatitis will be analyzed.

Detailed description

Several scoring systems are used to evaluate the prognosis of acute pancreatitis, but they are rather complicated and clinically less useful. Blood viscosity is associated with hematocrit and inflammatory factors known to be related to the prognosis of acute pancreatitis, and our group's previous study which is not yet published showed that blood viscosity better predicts severe acute pancreatitis than other single factors such as C-reative protein. Therefore, this study aims to prospectively evaluate the usefulness of blood viscosity as a prognostic factor for acute pancreatitis. During the study period, the study is conducted on patients with acute pancreatitis between the ages of 19 and 70, and patients with acute pancreatitis after ERCP are excluded. Blood viscosities at initial and 24 hours after hospitalization, and serum phosphate, which have shown potential as a predictor of severity in post-ERCP pancreatitis in previous studies are measured. The association of these blood biomarkers with the severity of acute pancreatitis will be analyzed and compared with hematocrit, C-reactive protein, etc., which are known as a single prognostic predictor of acute pancreatitis.

Interventions

None listed

Sponsors

In Seok Lee
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years

Inclusion criteria

* Age 19-70 years old * Acute pancreatitis

Exclusion criteria

* Post-Endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis

Design outcomes

Primary

MeasureTime frameDescription
Prediction of severity of acute pancreatitis using initial blood viscosity48hours after admissionEvaluate initial blood viscosity as a predictor of the severity of acute pancreatitis

Secondary

MeasureTime frameDescription
Prediction of severity of acute pancreatitis using blood viscosity change after 24hours24hours after admissionPrediction of severity of acute pancreatitis using blood viscosity change after 24hours
Prediction of severity of acute pancreatitis using serum phosphate48hours after admissionPrediction of severity of acute pancreatitis using serum phosphate

Countries

South Korea

Contacts

Primary ContactYoung Hoon Choi, MD, MS
crzyzs@naver.com82-2-2258-6020
Backup ContactIn Seok Lee, MD, PhD
isle@catholic.ac.kr82-2-2258-6022

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026